BioCryst Pharmaceuticals, Inc.
(NASDAQ : BCRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.23%104.921.1%$1268.51m
GILDGilead Sciences, Inc.
-0.03%72.800.9%$641.40m
AMGNAmgen Inc.
0.17%170.241.1%$478.73m
REGNRegeneron Pharmaceuticals, Inc.
0.77%390.512.7%$361.84m
BIIBBiogen Inc.
-0.40%308.571.2%$348.41m
ALXNAlexion Pharmaceuticals, Inc.
1.06%108.741.9%$269.47m
VRTXVertex Pharmaceuticals Incorporated
-0.13%146.851.9%$232.42m
ALNYAlnylam Pharmaceuticals, Inc
1.08%133.7610.0%$195.25m
INCYIncyte Corporation
-0.16%98.842.5%$178.95m
NKTRNektar Therapeutics
-1.14%49.186.1%$174.56m
ILMNIllumina, Inc.
0.00%215.353.5%$154.52m
JUNOJuno Therapeutics, Inc.
1.78%61.4013.5%$140.07m
AAgilent Technologies, Inc.
0.45%69.001.5%$132.25m
SRPTSarepta Therapeutics, Inc.
0.53%56.5216.8%$116.24m
BLUEBluebird Bio, Inc.
0.75%168.4517.2%$115.28m

Company Profile

BioCryst Pharmaceuticals, Inc. engages in the research, development, and commercialization of biopharmaceutical products. Its portfolio includes Rapivab, Kallikrein inhibitors, and BCX4430. These drugs intend to treat influenza and hereditary angioedema. The company was founded in 1986 and is headquartered in Durham, NC.